leadf
logo-loader
viewThe Valens Company
(
TSX:VLNSOTCQX:VLNCF
)

Valens inks deal with Rubicon Organics to develop customized Cannabis 2.0 products

The extraction and manufacturing agreement will allow Valens to leverage its full complement of proprietary extraction capabilities to deliver customized consumer experiences

The Valens Company -
Valens says the manufacturing agreement will provide it a platform for new product development and innovation to bring next-generation formats to the market

The Valens Company (TSE:VLNS) (OTCQX:VLNCF) (FRA:7LV) reported that it has entered into an extraction and custom manufacturing agreement with Canadian organic cannabis grower Rubicon Organics. 

Valens noted that the agreement will allow it to leverage the company’s full complement of proprietary extraction capabilities, including organic certified CO2, ethanol, and other extraction technologies, to deliver customized consumer experiences for a variety of Rubicon Organics’ Cannabis 2.0 products.

“The Rubicon Organics team has a strong and proven track record of success with their flower business and we are confident they will enjoy the same success in other product categories,” Valens CEO Tyler Robson said in a statement. 

READ: Valens scales up and begins to show what it was 'made to do'

He added: “We are especially pleased to be working with a supply partner that can meet our strict requirements for laboratory controls, quality and reliability.”

Rubicon Organics CEO Jesse McConnell also weighed in on the announcement, stating: “This agreement will enable Rubicon Organics to accelerate the launch of our organic certified 2.0 innovation pipeline, providing our consumers with the best cannabis products in Canada, and growing our share of the premium and super-premium cannabis category.”

As well, Valens said the custom manufacturing agreement provides a platform for collaboration, new product development and innovation to bring next-generation formats to the market, which is expected to allow the company to further expand its industry-leading portfolio of product manufacturing capabilities.

The Valens Company is a British Columbia-based producer of cannabis products, medical and recreational, and it is scaling up operations.

The company can process over 425,000 kilograms of biomass per year and its services include numerous types of proprietary extraction, analytical testing, formulation, cultivation, and research, as well as white label product development.

Its products include tinctures, two-piece caps, soft gels, oral sprays, and vape pens, as well as beverages, edibles, injectables, and natural health products and it has a strong pipeline of next-generation products in development.

Contact Sean at sean@proactiveinvestors.com

Quick facts: The Valens Company

Follow
TSX:VLNS

Price: 2.61 CAD

Market Cap: $452.37 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of named herein, including the promotion by the Company of in any Content on the Site, the Company receives from said issuer annual cash...

FOR OUR FULL DISCLAIMER CLICK HERE

The Valens Company take a large chunk of market share after acquisition of...

The Valens Company (TSX:VLNS, OTCQX:VLNCF) President Jeff Fallows joined Steve Darling from Proactive to share news about two major acquisitions the company has made that now puts them in a new tier in the cannabis sector. Fallows talks about the rationale behind the acquisition of Verse...

1 week, 1 day ago

2 min read